Maternal health and non‐communicable disease prevention: An investment case for the post COVID‐19 world and need for better health economic data

Kapur, Anil; Hod, Moshe

doi:10.1002/ijgo.13198

Cited by 20 publications

(22 citation statements)

References 66 publications

(92 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Currently, the United States also has the highest number of COVID‐19 infections worldwide 107 . In light of the global COVID‐19 pandemic, there has been a call for renewed prioritization of non‐communicable diseases such as obesity that increase susceptibility of women with SARS‐CoV‐2 infection to severe disease or mortality 108 . Carefully designed epidemiologic studies are required to assess the linkage between COVID‐19 disease severity, obesity, and associated socioeconomic factors.…”

Section: Resultsmentioning

confidence: 99%

Obesity as a contributor to immunopathology in pregnant and non‐pregnant adults with COVID‐19

McCartney

Kachikis

Huebner

et al. 2020

American J Rep Immunol

View full text Add to dashboard Cite

The emerging coronavirus disease 2019 (COVID-19) pandemic caused by infection with the novel betacoronavirus SARS-CoV-2 continues to challenge public health systems globally. Although the majority of patients with COVID-19 have self-limited disease consisting predominantly of mild respiratory symptoms, approximately 20%-30% develop acute respiratory distress syndrome (ARDS). 1-4 The Centers for Disease Control have recently refined their risk categories for COVID-19 to state that obesity

show abstract

Section: Resultsmentioning

confidence: 99%

Obesity as a contributor to immunopathology in pregnant and non‐pregnant adults with COVID‐19

McCartney

Kachikis

Huebner

et al. 2020

American J Rep Immunol

View full text Add to dashboard Cite

show abstract

“…The presence of chronic degenerative diseases is related to an increased risk of complications and death from COVID-19 [ 18 ], including in Mexico [ 19 ]. However, as other authors indicated previously [ 20 ], the impact of these highly prevalent diseases on the clinical evolution of COVID-19 in pregnant women has not been analyzed. We found that DM and chronic kidney disease are risk factors for death among patients of childbearing age with a positive test, but were not found as risk factors for mortality among pregnant patients with or without a positive test.…”

Section: Discussionmentioning

confidence: 99%

COVID-19 mortality among pregnant women in Mexico: A retrospective cohort study

Ríos-Silva

Murillo-Zamora

Mendoza-Cano

et al. 2020

Journal of Global Health

View full text Add to dashboard Cite

Background Pregnant women have been classified as at risk for COVID-19 due to previous experience with influenza and other coronaviruses. The objective of this study was to identify risk factors for the complications and death in women of childbearing age and pregnant women with suspected COVID-19. Methods This retrospective cohort study was conducted from the beginning of the epidemic in Mexico until May 25, 2020. All women of childbearing age (13-49 years) from the open national COVID-19 database from the Ministry of Health of Mexico were considered for eligibility. SARS-COV-2 infection was confirmed or ruled out by RT-qPCR. We performed a bivariate and multivariable analysis to estimate mortality risk. Results Ten (2.2%) pregnant women with confirmed COVID-19 died. Positive pregnant patients did not have a higher risk of complications (admission to the ICU, pneumonia, or requirement for mechanical ventilation) or death than the controls. In the multivariate analysis, only history of diabetes and chronic kidney disease remained independently associated with death in the positive cohort. Seven (0.6%) pregnant women with a negative test died. In bivariate analysis, pregnant patients with a positive test had a higher risk of death than pregnant patients with a negative test (relative risk (RR) = 3.87, 95% confidence interval (CI) = 1.48-10.12), but no higher risk was found than in non-pregnant women with a positive test (RR = 0.82, 95% CI = 0.44-1.53), and 60-day mortality did not significantly differ among pregnant patients with or without a positive test (hazard ratio (HR) = 0.40, 95% CI = 0.12-1.30) or between COVID-19-positive patients who were pregnant or not pregnant (HR = 0.74, 95% CI = 0.35-1.56). Conclusions Pregnant patients do not have a greater risk of complications or death from COVID-19 than non-pregnant patients. The presence of diabetes mellitus and chronic disease increases the risk of death in women of childbearing age, but not specifically in pregnant patients.

show abstract

“…The COVID-19 crisis has called for a reimagination of places, people, and strategies for healthcare organizations to prepare for the postpandemic phase ( 11 , 12 , 13 ). In this recovery process, we learned important lessons of effective, tailored communications, cross disciplinary teamwork, and innovative solutions.…”

Section: Discussionmentioning

confidence: 99%

Recover Wisely From COVID-19: Responsible Resumption of Nonurgent Radiology Services

et al. 2020

View full text Add to dashboard Cite

Rationale and Objectives: Following state and institutional guidelines, our Radiology department launched the "Recover Wisely" for all nonurgent radiology care on May 4, 2020. Our objective is to report our practice implementation and experience of COVID-19 recovery during the resumption of routine imaging at a tertiary academic medical center. Materials and Methods: We used the SQUIRE 2.0 guidelines for this practice implementation. Recover Wisely focused on a data driven, strategic rescheduling and redesigning patient flow process. We used scheduling simulations and meticulous monitoring and control of outpatient medical imaging volumes to achieve a linear restoration to our pre-COVID imaging studies. We had a tiered plan to address the backlog of rescheduled patients with gradual opening of our imaging facilities, while maintaining broad communication with our patients and referring clinicians. Results: Recover Wisely followed our anticipated linear modeling. Considering the last 10 weeks in the recovery, outpatient growth was linear with an increase of approximately 172 cases per week, (R 2 =0.97). We achieved an overall recovery of 102% in week 10, as compared to average weekly pre-COVID outpatient volumes. The modalities recovered as follows in outpatient volumes: CT (113%), MRI (101%), nuclear medicine including PET (138%), mammograms (97%), ultrasound (99%) and interventional radiology (106%). When compared to identical 2019 calendar weeks (May 4, 2020ÀJuly 10, 2020), the total 2020 radiology volume was 11% reduced from the 2019 volume. The reduction in total weighted relative value units was 8% in this time period, as compared to 2019. Conclusion: Our department utilized a data-driven, team approach based on our guiding principles to "Recover Wisely." We created and implemented a methodology that achieved a linear increase in outpatient studies over a 10-week recovery period.

show abstract

Maternal health and non‐communicable disease prevention: An investment case for the post COVID‐19 world and need for better health economic data

Cited by 20 publications

References 66 publications

Obesity as a contributor to immunopathology in pregnant and non‐pregnant adults with COVID‐19

Obesity as a contributor to immunopathology in pregnant and non‐pregnant adults with COVID‐19

COVID-19 mortality among pregnant women in Mexico: A retrospective cohort study

Recover Wisely From COVID-19: Responsible Resumption of Nonurgent Radiology Services

Contact Info

Product

Resources

About